KARACHI:
A vaccine developed for the treatment of coronavirus in China has started giving encouraging results and the results of experiments conducted on 100 people have come out positive.
Science Magazine reports that during the initial trial of the vaccine, 100 patients showed a good immune response to the virus.
The vaccine, called Ad5-nCoV, is being developed by CanSino Biologics, a Chinese company, and its experiments on humans began in March.
There are now 100 vaccines being developed around the world for the treatment of corona and 8 are being tested on humans.
The Ad5-nCoV vaccine includes a weaker version of the common cold virus called adenovirus, which infects human cells but does not cause disease.
The virus's job is to provide the immune system with genetic material from the corona virus's crown.
The idea behind the vaccine was that the human immune system would be able to produce antibodies against the coronavirus, which would enable the body to fight corona.
to research published in the scientific journal
The Lancet, the ad5-nCoV vaccine was used on 108% of healthy people between the ages of 18 and 60.
The study participants were divided into three groups, one of which was given a light dose of the vaccine, while the other two groups were given a medium and heavy dose.
Two weeks later, all the people started preparing the antibodies needed to fight corona, while by the 28th day, almost everyone had anti-corona antibodies.
According to experts, side effects include pain at the injection site, mild fever, fatigue, headache, and body aches.
No comments:
Post a Comment